- Home
- PRSU vs INBX Comparison
PRSU vs INBX Comparison
Compare PRSU & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRSU | INBX |
|---|---|---|
| Founded | 1926 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 1994 | 2024 |
Fundamental Metrics
Financial Performance| Metric | PRSU | INBX |
|---|---|---|
| Price | $47.33 | $95.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $31.67 | ★ $150.00 |
| AVG Volume (30 Days) | ★ 206.8K | 191.3K |
| Earning Date | 05-06-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,064,987,000.00 | $1,300,000.00 |
| Revenue This Year | $4.85 | N/A |
| Revenue Next Year | $4.94 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 9.48 | ★ 550.00 |
| 52 Week Low | $32.03 | $22.40 |
| 52 Week High | $56.52 | $155.29 |
Technical Indicators
Market Signals| Indicator | PRSU | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 57.85 |
| Support Level | $32.90 | $71.31 |
| Resistance Level | $54.24 | $96.12 |
| Average True Range (ATR) | 1.87 | 5.18 |
| MACD | -0.63 | 1.95 |
| Stochastic Oscillator | 25.62 | 73.31 |
Price Performance
Historical ComparisonAbout PRSU Pursuit Attractions and Hospitality Inc.
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, Iceland and Costa Rica. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.